- Home
- XBP vs IVVD Comparison
XBP vs IVVD Comparison
Compare XBP & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- IVVD
- Stock Information
- Founded
- XBP 2020
- IVVD 2020
- Country
- XBP United States
- IVVD United States
- Employees
- XBP N/A
- IVVD N/A
- Industry
- XBP Business Services
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- XBP Consumer Discretionary
- IVVD Health Care
- Exchange
- XBP Nasdaq
- IVVD Nasdaq
- Market Cap
- XBP 71.0M
- IVVD 63.4M
- IPO Year
- XBP N/A
- IVVD 2021
- Fundamental
- Price
- XBP $1.00
- IVVD $1.43
- Analyst Decision
- XBP
- IVVD Strong Buy
- Analyst Count
- XBP 0
- IVVD 4
- Target Price
- XBP N/A
- IVVD $3.64
- AVG Volume (30 Days)
- XBP 515.8K
- IVVD 15.0M
- Earning Date
- XBP 11-11-2025
- IVVD 11-13-2025
- Dividend Yield
- XBP N/A
- IVVD N/A
- EPS Growth
- XBP N/A
- IVVD N/A
- EPS
- XBP N/A
- IVVD N/A
- Revenue
- XBP $148,332,000.00
- IVVD $46,210,000.00
- Revenue This Year
- XBP N/A
- IVVD $385.94
- Revenue Next Year
- XBP N/A
- IVVD $62.62
- P/E Ratio
- XBP N/A
- IVVD N/A
- Revenue Growth
- XBP 0.23
- IVVD 1941.08
- 52 Week Low
- XBP $0.42
- IVVD $0.35
- 52 Week High
- XBP $2.56
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- XBP 69.34
- IVVD 72.86
- Support Level
- XBP $0.65
- IVVD $0.96
- Resistance Level
- XBP $0.90
- IVVD $1.45
- Average True Range (ATR)
- XBP 0.09
- IVVD 0.19
- MACD
- XBP 0.05
- IVVD 0.05
- Stochastic Oscillator
- XBP 97.70
- IVVD 97.86
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.